摘要
目的 探讨分析吗啡与二羟丙茶碱在肿瘤患者呼吸困难中的应用价值.方法 选择在医院进行治疗的肿瘤呼吸困难患者58例,具体的选择时间为2018年4月—2019年4月,随机将患者分为参照组和试验组,每组29例,参照组行二羟丙茶碱治疗,在此基础上试验组行吗啡治疗,对两组患者的呼吸困难情况标及治疗效果进行比较分析.结果 治疗前,两组患者的Brog、VAS评分差异无统计学意义(P>0.05).治疗后,参照组患者的Brog、VAS评分较试验组更高,治疗有效率较试验组更低,差异具有统计学意义(P<0.05).结论 对肺癌呼吸困难患者进行吗啡与二羟丙茶碱的联合治疗,能有效改善患者的呼吸困难程度,提高治疗效果,具有一定的临床使用价值.
Objective To investigate the value of morphine and dihydroxypropyltheophylline in dyspnea of cancer patients.Methods 58 patients with dyspnea due to tumors were randomly divided into the reference group and the experimental group from April 2018 to April 2019.29 patients in each group were treated with dihydroxypropyltheophylline in the reference group.Morphine was given to the experimental group on this basis.The symptoms and therapeutic effects of dyspnea in the two groups were compared and analyzed.Results Before treatment,there was no significant difference in Brog and VAS scores between the two groups(P>0.05).After treatment,the Brog and VAS scores of the reference group were higher than those of the experimental group,and the effective rate of treatment was lower than that of the experimental group,with statistical significance(P<0.05).Conclusion The combined treatment of morphine and dihydroxypropyltheophylline for lung cancer patients with dyspnea can effectively improve the degree of dyspnea and improve the therapeutic effect,which has a certain clinical value.
作者
艾德惠
AI Dehui(Department of Respiratory Oncology,Chongqing Southeast Hospital,Chongqing 401336,China)
出处
《中国继续医学教育》
2020年第10期108-110,共3页
China Continuing Medical Education
关键词
价值
肿瘤
二羟丙茶碱
吗啡
呼吸困难
血气指标
value
tumor
dihydroxypropyltheophylline
morphine
dyspnea
blood gas index